– Johnson & Johnson beat estimates by 11 cents a share, with quarterly earnings of $2.67 per share. Revenue came in slightly below forecasts.
J&J also suspended sales guidance for its Covid-19 vaccine due to a global supply surplus, and announced a 6.6% dividend hike. Shares initially fell more than 3% in the premarket but subsequently erased those losses.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCDFW - 🏆 288. / 63 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »